Avtor/Urednik		Šorli, J
Naslov		The effect of cost evaluation in the treatment of asthma
Tip		članek
Vir		Med Arh
Vol. in št.		Letnik 53, št. 3 suppl 1
Leto izdaje		1999
Obseg		str. 15-7
Jezik		cro, eng
Abstrakt		Aim: To present value of cost effectiveness evaluation in asthma treatment Material and methods. Meta-analysis of asthma treatment studies compared with data from National Healthcare Plan in Slovenia. Results: Patients treated with fluticasone propionate (FP) were successfully controlled for 41.7% of treated weeks compared with 34.1% in the group treated with budesonide (B) (p < 0.001). Purchase price for FP (1.524 SIT/week) is not significantly different from B (1.462 SIT/week). The overall mean weekly cost per patient was 3.077 SIT for patient treated with B and 1.916 SIT for patient treated with FP. Cost of health care contacts were 56 SIT in the FP group and 1.275 SIT in B group per week. The total expenditure per week of successful treatment would be 4.594 SIT/week in the FP group and 9.025 SIT/week in patients treated with B. Discussion: It is evident that by evaluation of purchase price only no final conclusion of cost effectiveness of treatment of asthma is possible. Conclusion: Limited resources in the health care could be properly distributed only after carefully weighting costs and comparing outcomes.
Deskriptorji		ASTHMA ANDROSTADIENES BRONCHODILATOR AGENTS CHILD ADULT COST-BENEFIT ANALYSIS ANTI-ASTHMATIC AGENTS ANTI-INFLAMMATORY AGENTS